טוען...
Therapeutic targeting of TAZ and YAP by dimethyl fumarate in systemic sclerosis fibrosis
Systemic sclerosis (scleroderma, SSc) is a devastating fibrotic disease with few treatment options. Fumaric acid esters, including dimethyl fumarate (DMF, Tecfidera(®)) have shown therapeutic effects in several disease models, prompting us to determine whether DMF is effective as a treatment for SSc...
שמור ב:
| הוצא לאור ב: | J Invest Dermatol |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5742036/ https://ncbi.nlm.nih.gov/pubmed/28870693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jid.2017.08.024 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|